Aspergillus fumigatus is a filamentous fungus that can cause severe respiratory disease in immunocompromised individuals. A putative sialidase from A. fumigatus was recently cloned and shown to be relatively poor in cleaving Nacetylneuraminic acid (Neu5Ac) in comparison to bacterial sialidases. Here we present the first crystal structure of a fungal sialidase. When the apo structure was compared to bacterial sialidase structures, the active site of the Aspergillus enzyme suggested that Neu5Ac would be a poor substrate due to a smaller pocket that normally accommodates the acetamido group of Neu5Ac in sialidases. A sialic acid with a hydroxyl in place of an acetamido group is 2-keto-3-deoxynononic acid (KDN). We show that KDN is the preferred substrate for the A. fumigatus sialidase and that A. fumigatus can utilise KDN as a sole carbon source. A 1.45Å resolution crystal structure of the enzyme in complex with KDN reveals KDN in the active site in a boat conformation, and nearby a second binding site occupied by KDN in a chair conformation, suggesting that polyKDN may be a natural substrate. The enzyme is not inhibited by the sialidase transition state analogue 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Neu5Ac2en) but is inhibited by the related KDN2en that we show bound to the enzyme in a 1.84Å resolution crystal structure. Using a fluorinated KDN substrate, we present a 1.5Å resolution structure of a covalently bound catalytic intermediate. The A. fumigatus sialidase is therefore a KDNase with a similar catalytic mechanism to Neu5Ac exosialidases, and this study represents the first structure of a KDNase.
Sialic acids comprise the most chemically and structurally diverse carbohydrate family. Over 50 naturally occurring analogues exist, the majority based on 5-acetamido-3,5-dideoxy-D-glycero-Dgalacto-non-2-ulosonic acid (N-acetylneuraminic acid, Neu5Ac, 1) and 3-deoxy-D-glycero-D-galactonon-2-ulosonic acid (2-keto-3-deoxynononic acid, KDN, 2) that only differ at the C5 position (1) . KDN, like Neu5Ac, occurs widely in bacteria and vertebrates, is found in almost all types of glycoconjugates including glycolipids, glycoproteins and capsular polysaccharides, and can be linked 2,3-, 2,4-, 2,6-or 2,8-to other carbohydrates (2). KDN was first discovered in the cortical alveolar polysialoglycoprotein of rainbow trout eggs as the capping carbohydrate on polysialic acid chains that were resistant to bacterial sialidases (3) . In mammals, KDN was first identified in various tissues including human lung carcinoma cells but at a much lower abundances than Neu5Ac (4), and was subsequently found on human red blood cells and ovarian cancer cells (5) . The development of linkage specific KDN antibodies (6, 7) has allowed the identification of 2,8-linked polyKDN in many mammalian tissues (8) , including the human lung (9) .
Sialidases, or neuraminidases, catalyse the removal of terminal sialic acids from a variety of glycoconjugates and play an important role in pathogenesis, bacterial nutrition and cellular interactions. Crystal structures of a growing number of exo-sialidases that cleave Neu5Ac are available from bacteria (10) (11) (12) (13) (14) (15) (16) , viruses (17) (18) (19) , trypanosomes (20, 21) , leech (22) and man (23) . All sialidases share the same six-bladed -propeller fold for their catalytic domains, with conservation of key catalytic amino acids (24) . The non-viral sialidases have an R-I/L-P motif containing one of the three active site arginines, and also have up to five bacterial neuraminidase repeats (BNRs) or Aspboxes (S/T-X-D-[X]-G-X-T-W/F). The BNRs occur at topologically identical positions in the -propeller fold, remote from the active site, but any function beyond dictating a structural fold is unknown. Like many glycosyl hydrolases, sialidases can possess carbohydrate-binding modules (CBMs) in addition to the catalytic domain, placed upstream, downstream or even inserted within the -propeller domain. It has been suggested that the presence of these CBMs increases the catalytic efficiency of the sialidases, particularly in the presence of polysaccharide substrates (25) . In the case of sialidases having CBMs, these often recognise sialic acid as has been shown for the sialidases from Vibrio cholerae (26) , Clostridium perfringens (27) and Streptococcus pneumoniae (15) . Nearly all Neu5Ac-specific sialidases are inhibited by 2-deoxy-2,3-dehydro-N-acetyl-neuraminic acid (Neu5Ac2en, 3), a putative transition-state analogue.
A sialidase specific for KDN ketosidic linkages was first discovered in the bacterium Sphingobacterium multivorum, and this so-called KDNase released KDN from naturally occurring substrates, including KDNα2-3Gal, KDNα2-6GalNAc, and KDNα2-8KDN linkages, but was not inhibited by Neu5Ac2en (28, 29) . The KDNase was however inhibited by 2,3-didehydro-2,3-dideoxy-D-glycero-D-galacto-nonulosonic acid (KDN2en, 4) (30) . Further analysis of this enzyme using synthetic KDN analogues suggested that the hydroxyl group at C5 was important for recognition of the inhibitor by the enzyme, and that like the Neu5Ac sialidases, the thermodynamically less stable -form of the product is the first product of cleavage, suggesting a similar catalytic mechanism to the Neu5Ac exosialidases (30, 31) .
Aspergillus fumigatus is a common soil fungus and is the major species of Aspergillus that causes invasive aspergillosis in immunocompromised humans (32) . Infection by A. fumigatus is mainly through inhalation of airborne conidiospores (conidia) that adhere to lung tissue. It has been shown that A. fumigatus conidia have surface sialic acids that may adhere to basal lamina proteins (33) , and that pathogenic species of Aspergillus have a higher density compared to non-pathogenic species (34) . The origin of these sialic acids remains a mystery, as although sialic acid biosynthesis has reported to occur de novo in A. fumigatus (34) , its genome appears to lack the known Neu5Ac biosynthetic enzymes. In addition, A. fumigatus is incapable of utilising or incorporating exogenous Neu5Ac or ManNAc (35) . Nevertheless, A. fumigatus does encode a sialidase that has recently been cloned and characterised (36) .
The A. fumigatus sialidase has a 20-amino acid signal peptide, an RIP motif, one BNR, and shares 30% sequence identity with the bacterial sialidase from Micromonospora viridifaciens whose structure is known (37) (36) . Briefly, E. coli expressing the AfS/pET28A+ vector were grown in Luria Broth with 50 μg/ml kanamycin at 37 °C, shaking at 220 rpm. Once the culture OD 600 had reached 0.9 AfS expression was induced by 0.5 mM IPTG (Isopropyl thio-β-D-galactopyranoside) and incubated overnight. Cells were then harvested by centrifugation at 16,780g for 25 mins and resuspended in phosphate buffered saline (50mM NaH 2 PO 4 , 300 mM NaCl, pH8) with EDTA-free Protease inhibitor cocktail (one tablet per 25 ml of solution; Roche Diagnostics) and DNase I (Sigma, final concentration 20 μg/ ml) and sonicated 5 times for 30 s. The sonicated culture was then centrifuged to remove insoluble cell debris at 37,000 g for 30 mins. The supernatant was then filtered through a 0.22 μm pore syringe driven filter before being loaded onto a 5ml HisTrap column (GE Healthcare) equilibrated with PBS. The bound protein was eluted with 5 column volumes of 300 mM imidazole in PBS. The eluted fraction was then subjected to size exclusion chromatography by loading onto a 120ml Sephacryl S-200 column (GE Healthcare). Fractions containing AfS were identified and purity assessed by SDS-PAGE and matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Fractions containing high purity AfS where then pooled, concentrated and diluted into 50 mM Tris-HCl, 100 mM NaCl, pH 8, then stored at -20 °C.
Selenomethionine incorporation -E. coli expressing the AfS/pET28A+ vector were grown in 150 ml LB with 50 μg/ml at 37 °C, shaking at 220 rpm overnight. Cells were harvested by centrifugation at 16,800 g for 20 mins at 4 °C. The supernatant was discarded and the pellet was re-suspended in 100 ml PBS and re-centrifuged. Supernatant was discarded and the pellet re-suspended in 4 ml PBS and added to 1 L sterile Selenomethionine (SeMet) media (17 mM NH 4 Cl, 22 mM KH 2 PO 4 , 6 mM Na 2 HPO 4 7H 2 O, 25 μM Fe 2 (SO 4 ) 3 and 30 μM thiamine, 20% w/v glucose, 0.3% w/v MgSO 4 ). Addition of 50mg of selenomethionine and kanamycin (50μg/ml) was then made to the selenomethionine minimal media. The culture was incubated at 37 °C shaking at 200 rpm until OD 600 reached 0.9 when AfS expression was induced by 0.5 mM IPTG and incubated overnight. Cells were harvested and AfS extracted and purified as above.
Protein crystallization -The optimal AfS concentration for crystal trials was determined as 13.7 mg/ml by pre-crystallization assay (Hampton Research). Sitting-drop vapour diffusion plates, held at 20 °C were used for all crystallization experiments. To ascertain crystallization conditions for AfS, commercial screens Cryo I and II (Emerald Biosystems), Crystal screens I and II and Index (Hampton Research), PEG screen (Qiagen) and Wizard (Emerald Biosystems) were used. Purified AfS was added to each screen condition in a 1:1 ratio by the high throughput Rhombix Screen robot.
Crystals from the PEG screen (Qiagen), condition 20% (w/v) polyethylene glycol (PEG) 3350 and 0.2 M sodium nitrate, appeared after four days and did not require any optimisation. AfS with selenomethionine incorporated crystallised in identical conditions. The structures of AfS in complex with KDN, KDN2en and 2,3F-KDN were achieved by soaking AfS crystals by addition of 1 μl of 70 mM KDN-MU, 100 mM KDN2en (38) or 500mM 2,3F-KDN, respectively, to 4 μl well containing 1:1 ratio of 13.7 mg/ml AfS and 20% (w/v) PEG 3350 and 0.2 M sodium nitrate and leaving for 20 mins. The synthesis of KDN-MU and 2,3F-KDN is described in the supplementary information.
Data collection -Crystals were cryoprotected by transfer to 20% (w/v) glycerol in crystallization buffer for a few seconds prior to placement in liquid nitrogen. Native data and the KDN2en complex were collected at 100 K in-house (Rigaku-MSC Micromax-007 X-ray generator and Saturn 944+ CCD detector). Data at the selenium absorption edge, the KDN complex and the covalent complex were collected on beamlines ID23-1, ID29 and ID14-1, respectively, at the European Synchrotron Radiation Facility (ESRF), Grenoble. MOSFLM (39) and the CCP4 suite (40) were used to integrate and scale the diffraction data. Crystals of AfS belong to space group P2 1 .
Structure determination and refinement -The structure of AfS was solved by SAD (single wavelength anomalous diffraction) using data collected at the selenium absorption peak. The selenium peak was at 0.9794Å , as determined by a crystal florescence scan. The selenium sites were determined using SHELXD (41) from the anomalous differences. SHELXE (41) was used to resolve the phase ambiguity and to apply density modification, resulting in an electron density map with a clear protein/solvent boundary and a polyalanine interpretation of the backbone of a large part of the structure. The phases from SHELXE were used in Phenix (42), together with the amino acid sequence to automatically build an initial structure at 2.15Å . The model of the apo structure was refined in REFMAC5 (43) using in-house data collected from a SeMet crystal data to 1.84Å and manually fitted/improved with Coot (44) and validated by Coot and MolProbity (45) . The structures of AfS in complex with ligands were refined similarly. Data collection and refinement statistics, together with PDB codes of the deposited structures are given in Table 1 .
Sialidase and KDNase activity assays -The activity of enzyme preparations was determined by measuring cleavage of the synthetic sialic acid substrate, 4-methylumbelliferyl α-D-Nacetylneuraminide (Neu5Ac-MU, 5, Sigma, Oakville, ON), or KDN-MU (synthesis described in supplementary materials). Briefly, reactions were set up in 96-well plates by adding 200 µM Neu5Ac-MU or KDN-MU, purified recombinant enzyme and the specific reaction buffer for a total volume of 100 µl. Plates were incubated at 37ºC for 10 minutes followed by the addition of 200 µl cold stop solution (0.1 M glycine, 0.014 M NaCl, 25% ethanol, pH 10.7). Following the addition of stop solution, the amount of 4-methylumbelliferone released from Neu5Ac-MU or KDN-MU was determined using a fluorescence spectrophotometer at excitation and emission wavelengths of 365 and 450 nm, respectively. Fluorescence produced during the course of the reaction was related to the concentration of Neu5Ac-MU or KDN-MU cleaved by comparison with a standard curve of 4-methylumbelliferone (Sigma). Each reaction was performed in triplicate.
Kinetic assay -Michaelis-Menten parameters for the AfS and MvS were measured using Neu5Ac-MU or KDN-MU. Each 100µl reaction mixture was incubated at 37ºC for 1 minute prior to addition of either purified sialidase. The progress of the reaction was continuously monitored for 20 minutes using a fluorescence spectrophotometer equipped with a temperature controller set to 37ºC and excitation and emission wavelengths of 365 and 450 nm, respectively. For Neu5Ac-MU, kinetic parameters were determined from 19 initial rate measurements using a substrate concentration range of 50 µM to 5000 µM. For KDN-MU, kinetic parameters were determined from 22 initial rate measurements using a substrate concentration range of 10 µM to 800 µM. The rate versus substrate concentration data were fitted to the MichaelisMenten equation using GraphPad (GraphPad Software Inc., San Diego, CA).
pH profile -The optimal pH of the purified enzyme was determined by measuring its specific activity (nmol. mg -1 . min -1 ) towards KDN-MU in buffers of varying pH. The buffers used were 40 mM sodium formate (pH 3 -3.5), 50 mM sodium acetate (pH 4 -5), 16 mM sodium tartrate (pH 5.2), 32.5 mM 2-(Nmorpholino)ethanesulfonic acid (MES) (pH 6 -7), 40 mM 3-(N-morpholino)propanesulfonic acid (MOPS) (pH 6.5), and 50 mM Tris-HCl (pH 7.5 -9). The ionic strength of all buffers was maintained at 100 mM with NaCl and all buffers were prepared for use at 37ºC. H 2 O and placed in a 5 mm NMR tube. Reaction mixtures were incubated at room temperature and spectra recorded at 0, 0.5, 1, 5, 12 and 24 hours. All NMR spectra were recorded at 298 K using a 500 MHz Bruker spectrometer taking 64 scans with a 2 s relaxation delay. During the relaxation delay the remaining water signal was suppressed by continuous low power irradiation.
Carbon source utilization -To determine the preferred carbon source use by A. fumigatus, 10 4 A. fumigatus spores were inoculated per well in 96-well plates containing chemically defined media with 25 mM carbon source of glucose, mannose, KDN, or sialic acid, or with no carbon source. All carbon sources were tested in triplicate. The KDN contained a maximum of 5% mannose; therefore, a K(+0.05MAN) sample, which contains 1.25 mM mannose, was tested to ensure that the small amount of mannose in the KDN sample did not contribute significantly to fungal growth. All media were adjusted to ~ pH 6.5 prior to inoculation. A paraffin overlay (50 l) was added to each well to prevent cross contamination of spores between wells. All plates were placed in a moist chamber and incubated at 37°C. Growth of the fungus was monitored spectrophotometrically at OD 620nm (Expert Plus Microplate Reader, Biochrom Asys). (Figure 2) . A more extensive excursion at the same topological position exists in the NanI sialidase from Clostridium perfringens (13) and the NanA/NanB sialidases from Streptococcus pneumoniae (15, 16) . Afs is a basic protein with a theoretical pI of 9.3, and this is reflected in the electrostatic potential surface that shows a predominantly positive surface around the active site and extending in a groove down and below the molecule (Figure 2 ). This is in contrast to secreted bacterial sialidases that tend to have a highly acidic surface on one side that, it is suggested, helps orient the enzyme in the neighbourhood of a negatively charged surface (13, 15, 26) . Behind the active site and below the cap domain there is a metal binding site (Figure 2) . The bond lengths are consistent with the binding of sodium or calcium. The metal ion is secured by the side chains of Asp 87 and Asn 89 as well as the backbone carbonyls of Gly 116 and Gly 118 . Two water molecules sit directly above and below the metal ion completing the octahedral stabilisation of the ion.
RESULTS

Overall structure -
A superposition of the MvS-Neu5Ac2en complex (PDB code 1eus) onto AfS shows conservation of key residues in the active site (Figure 3) . These include the arginine triad, the nucleophilic tyrosine and its associated glutamic acid, and the acid/base aspartic acid. Neu5Ac2en is not an inhibitor of AfS, and this may be explained, in part, by the presence of Arg 171 in AfS protruding into the hydrophobic pocket that usually accommodates the acetamido group of Neu5Ac2en (Figure 3 ). This suggested that AfS recognises a sialic acid with a smaller group at C5. The only sialic acids with a smaller group at C5 are neuraminic acid, that has an amino group at C5 but does not occur naturally, and KDN that has a hydroxyl at C5 (1). (47) , therefore AfS has a similar catalytic efficiency with KDN-MU as MvS has with Neu5Ac-MU. AfS has a pH optimum of between 3.5 and 4.5 with KDN-MU, similar to its optimum with Neu5Ac-MU (36) . The optimal temperature range of AfS with KDN-MU was from 30 to 37 C.
Kinetic analysis shows AfS prefers KDN over
Crystal structure of AfS complexed with KDN -The structure derived from a crystal of AfS soaked in KDN-MU revealed two KDN molecules bound per monomer (Figures 4, 5) . One KDN occupies the active site and is in a boat conformation, the second occupies a positively-charged site (site 2 in Figure  2 ) adjacent to the active site such that the distance from the anomeric oxygen of the active site KDN is only 6.4Å from C9 and 7.7Å from C8 of the second KDN. Intriguingly, in monomer B, there is a glycerol molecule from the cryoprotectant sitting between the two KDN molecules (Figures 4,5) .
Active site of AfS -KDN in the active site is bound in its -anomeric form, with the ring adopting a distorted B 2,5 boat conformation. The O2 hydroxyl of KDN forms a close interaction (2.57Å ) with Asp 84 and also interacts with the bound glycerol (2.71Å ). Although there are a number of significant differences between the active sites of viral, bacterial and eukaryotic sialidases, a number of key features have been retained throughout their evolution (24) , and are shown in Figure 4 . These include a tri-arginal cluster ( (49) and C. perfringens NanI (13) (Figure 8 ) The hydrolysis of KDN-MU to form KDN was monitored as a time course reaction using 1 H NMR spectroscopy in deuterated buffer at a pD of 3.6. The H3 eq proton of KDN-MU has a characteristic doublet of doublets ( = 2.75 ppm, J 3e,3a = 12.7 Hz, J 3e,4 = 4.7 Hz). With the addition of AfS, cleavage of the umbelliferyl group leads to a shift of the H3 eq resonance to  = 2.60 ppm of the KDN product. Over time KDN mutarotates to the thermodynamically more stable KDN with the appearance of H3 eq resonance at  = 2.10 ppm. No trans-sialidase activity was observed for AfS (data not shown).
NMR monitoring of KDN-MU hydration by AfS -
A. fumigatus can utilise KDN as a sole carbon source -To determine whether KDN could be a carbon source for A. fumigatus, we measured growth in defined media supplemented with various carbon sources ( Figure 9 ). The data indicate that A. fumigatus is unable to use Neu5Ac as the sole source of carbon; however, it is able to use KDN though less efficiently on a molar basis compared to glucose. There was also a short lag in growth suggesting that KDN catabolic enzymes must be induced prior to utilization of this substrate.
DISCUSSION
The structure of the sialidase (AfS) from A. fumigatus presented here represents the first structure of a fungal sialidase, and the first structure of a KDN-specific sialidase, or KDNase. The KDN complex reveals two KDN molecules bound per monomer ( Figures 4&5) . The structural details of this complex, the complex of AfS with KDN2en, and the covalent intermediate suggest a similar mechanism for AfS as has been described for other Neu5Ac-specific exo-sialidases, as all of the key catalytic residues are conserved and occupy near identical positions (Figure 3) . Although the KDN in the active site is the product of KDN-MU hydrolysis, it has its sugar ring in a strained and distorted B 2,5 conformation that is reminiscent of the induced sialic acid ring conformation seen in the Michaelis complexes between an aspartic acid mutant of T.cruzi trans-sialidase and (2,3)-sialyllactose (48) and in wild-type NanI sialidase from C. perfringens with Neu5Ac (13). This conformation of the sugar ring results in a pseudo-axial orientation of the glycosidic bond being cleaved, bringing it within 2.6 Å of the acid catalyst Asp Figure 7B ). With a KDN glycan it is likely that catalysis would proceed with the concomitant release of the aglycon moiety as described for other sialidases (13) . This similarity between the mechanism of AfS and other sialidases is further supported by the NMR data (Figure 8 ) that show that catalysis proceeds with retention of configuration at the anomeric carbon of KDN.
The catalytic efficiency of AfS in cleaving the 4-methylumbelliferyl leaving group from KDN-MU is 10 5 times greater than its ability to cleave the same leaving group from Neu5Ac-MU. In addition, AfS is not inhibited by Neu5Ac2en, the transition state analogue of Neu5Ac-hydrolysing sialidases. The specificity of AfS KDNase for KDN lies in the nature of the pocket that accommodates the C5 hydroxyl, as had been predicted (30 in AfS sits at the start of the third strand of the second -sheet of the -propeller, and is seven residues before the start of an Asp-box. In the structures of Neu5Ac-sialidases, the equivalent residue occupying the same structural position is a serine (C. perfringens, S. pneumoniae), threonine (human Neu2) or leucine (M. viridifaciens), and the residue forms part of the larger, more hydrophobic pocket accommodating the acetamido group of Neu5Ac. Mutagenesis of Arg 171 will perhaps show if this is a determinant of KDN binding.
The discovery of a second KDN binding site adjacent to the active site is an unusual finding for an exo-sialidase. Many bacterial and parasite sialidases or trans-sialidases possess additional carbohydrate-binding modules (CBMs) that often recognise sialic acid (15, 26, 27) . The presence of these modules increases catalytic efficiency of the enzyme by targeting the sialidase to appropriate substrates (50) . However, these CBMs are distinct domains and the sialic acid binding site in the CBM is typically at least 30 Å from the active site. In addition, bacterial sialidases often have an asymmetric charge distribution over their surface with the side opposite the active site being highly negatively charged, and this is thought to assist the orientation of the active site towards negativelycharged sialic acid substrates. In contrast, the surface of AfS is mainly positively charged and the second KDN sits in a basic pocket only 7Å from the active site KDN. The second KDN is its -anomeric form, with the ring adopting a low energy 2 C 5 chair conformation, and with its anomeric oxygen pointing away from the surface of AfS. There is a positively charged groove running down and underneath the AfS surface beyond this second KDN (Figure 2 ). In the complex with a fluorinated KDN, two 2,3F-KDN molecules in a 2 C 5 chair conformation occupy part of this groove. This is therefore suggestive of polyKDN being a preferred substrate of AfS. A positively-charged groove also extends along the surface of the bacteriophage K1F tailspike protein, an endosialidase that recognises and degrades 2,8-linked polyNeu5Ac (51 A. fumigatus is the most prevalent airborne fungal pathogen, causing severe and often fatal invasive infections in immunocompromised hosts (reviewed in (32) ). The conidia released by the fungus are small enough to reach the lung alveoli, and the resulting disease called invasive aspergillosis occurs predominantly in the lungs. Intriguingly, polyKDN has been found in the human lung, as well as in other tissues, identified through the use of a monoclonal antibody recognising 2,8-linked KDN molecules (4, 9) . PolyKDN in the lung is a relatively minor component of glycoproteins and glycolipids compared to Neu5Ac, and is reported to be associated with a developmentally-regulated 150kDa glycoprotein not present in adults, but present in various types of human lung tumours (52) . The results presented here from a structural analysis of the A. fumigatus KDNase suggest further explorations into its role in nutrition or pathogenesis. 
TABLES
